Beyond weight loss | GLP-1 pipeline market insight

Note that metabolic and immunological drug development will be the second largest pole of growth beyond the tumor

CAR-T cell therapy for systemic lupus erythematosus is effective!

Microfluidic technology and its application in the IVD field

Modified transdermal formulation considerations from the CDE approved product

The whole chain supports the innovative drug development plan, and discusses the influence on the future drug access